Financials Universal Biosensors, Inc.

Equities

UBI

AU000000UBI2

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 01:50:07 2024-04-26 am EDT 5-day change 1st Jan Change
0.15 AUD -11.76% Intraday chart for Universal Biosensors, Inc. -9.09% -25.00%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 38.95 33.74 77.26 176 47.66 42.47
Enterprise Value (EV) 1 27.15 3.509 57.86 163 26.52 37.2
P/E ratio 1.05 x -6.33 x -10.1 x -16.7 x -1.67 x -6.3 x
Yield - - - - - -
Capitalization / Revenue 0.56 x 4.89 x 24.1 x 30.5 x 10.5 x 6.4 x
EV / Revenue 0.39 x 0.51 x 18.1 x 28.2 x 5.86 x 5.61 x
EV / EBITDA 0.56 x -0.39 x -5.71 x -13.1 x -1.26 x -2.37 x
EV / FCF -2.38 x 0.13 x -6.93 x -18.7 x -2.38 x -1.87 x
FCF Yield -42% 759% -14.4% -5.34% -42% -53.4%
Price to Book 0.77 x 0.74 x 2.03 x 6.38 x 1.83 x 2.18 x
Nbr of stocks (in thousands) 177,052 177,572 177,612 177,819 211,844 212,369
Reference price 2 0.2200 0.1900 0.4350 0.9900 0.2250 0.2000
Announcement Date 2/22/19 2/26/20 2/24/21 2/24/22 2/24/23 2/29/24
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 69.46 6.897 3.203 5.778 4.525 6.633
EBITDA 1 48.54 -8.89 -10.13 -12.47 -21.09 -15.71
EBIT 1 46.42 -10.4 -12.56 -15.04 -23.88 -16.68
Operating Margin 66.84% -150.78% -392.12% -260.28% -527.71% -251.48%
Earnings before Tax (EBT) 1 41.92 -6.164 -7.638 -10.51 -29.91 -6.742
Net income 1 37.56 -4.846 -7.638 -10.51 -26.85 -6.742
Net margin 54.08% -70.26% -238.49% -181.85% -593.48% -101.64%
EPS 2 0.2100 -0.0300 -0.0430 -0.0591 -0.1351 -0.0317
Free Cash Flow 1 -11.42 26.63 -8.345 -8.703 -11.14 -19.86
FCF margin -16.44% 386.12% -260.57% -150.63% -246.17% -299.48%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 2/22/19 2/26/20 2/24/21 2/24/22 2/24/23 2/29/24
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S1 2022 S2
Net sales 1 3.084 1.441
EBITDA - -
EBIT 1 -11.19 -23.71
Operating Margin -362.75% -1,644.98%
Earnings before Tax (EBT) - -
Net income 1 -9.179 -17.68
Net margin -297.65% -1,226.47%
EPS - -
Dividend per Share - -
Announcement Date 8/10/22 2/24/23
1AUD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 11.8 30.2 19.4 13.1 21.1 5.27
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -11.4 26.6 -8.35 -8.7 -11.1 -19.9
ROE (net income / shareholders' equity) 118% -10.1% -18.3% -32% -100% -29.6%
ROA (Net income/ Total Assets) 49.9% -9.8% -13.2% -18.6% -32.9% -27.4%
Assets 1 75.25 49.45 57.92 56.39 81.55 24.61
Book Value Per Share 2 0.2900 0.2600 0.2100 0.1600 0.1200 0.0900
Cash Flow per Share 2 0.0700 0.1700 0.1300 0.0900 0.1200 0.0500
Capex 1 0.45 10.3 0.39 0.66 1.57 1.47
Capex / Sales 0.65% 149.44% 12.09% 11.5% 34.59% 22.21%
Announcement Date 2/22/19 2/26/20 2/24/21 2/24/22 2/24/23 2/29/24
1AUD in Million2AUD
Estimates
  1. Stock Market
  2. Equities
  3. UBI Stock
  4. Financials Universal Biosensors, Inc.